CN Patent

CN108778266A — 包含二高γ亚麻酸（DGLA）的医药组合物和其用途

Assigned to Ds Biopharmaceutical Co ltd · Expires 2018-11-09 · 8y expired

What this patent protects

本公开提供了包含DGLA的可经口递送医药组合物以及使用其治疗多种病状和病症的方法。

USPTO Abstract

本公开提供了包含DGLA的可经口递送医药组合物以及使用其治疗多种病状和病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108778266A
Jurisdiction
CN
Classification
—
Expires
2018-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Ds Biopharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.